Helix BioPharma Corp. Finalizes Polish Subsidiary Divestiture

Stock Information for Huttig Building Products Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Huttig Building Products Inc.

Canadian Investment Regulatory Organization Trade Resumption - HBP
Canadian Investment Regulatory Organization Trading Halt - HBP
Helix BioPharma Corp. Reports Voting Results
Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results
Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results
Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes
Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.